| Literature DB >> 35011012 |
Diana Plamada1, Dan Cristian Vodnar1,2.
Abstract
The present review summarizes the studies carried out on this topic in the last five years. According to the new definitions, among all the compounds included in the group of prebiotics, polyphenols are probably the most important secondary metabolites produced by the plant kingdom. Many of these types of polyphenols have low bioavailability, therefore reaching the colon in unaltered form. Once in the colon, these compounds interact with the intestinal microbes bidirectionally by modulating them and, consequently, releasing metabolites. Despite much research on various metabolites, little is known about the chemistry of the metabolic routes used by different bacteria species. In this context, this review aims to investigate the prebiotic effect of polyphenols in preclinical and clinical studies, highlighting that the consumption of polyphenols leads to an increase in beneficial bacteria, as well as an increase in the production of valuable metabolites. In conclusion, there is much evidence in preclinical studies supporting the prebiotic effect of polyphenols, but further clinical studies are needed to investigate this effect in humans.Entities:
Keywords: bacteria; bioactive compounds; gut microbiota; polyphenols; prebiotics
Mesh:
Substances:
Year: 2021 PMID: 35011012 PMCID: PMC8747136 DOI: 10.3390/nu14010137
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Figure 1Prebiotic classification (GOS, galactooligosaccharides; FOS, fructooligosaccharides; XOS, xylooligosaccharides, IMO, isomaltooligosaccharides; PUFAs, polyunsaturated fatty acids) [38].
The classification of polyphenols was adapted after Wiciński et al. [40].
| Class | Subclass | Examples of Compounds | Source | References |
|---|---|---|---|---|
| Coumarin | Simple coumarins | Esculetin | Seeds | [ |
| Tannins | Complex tannins | Tannic acid | Bark | [ |
| Phenolic acids | Hydroxycinnamic acids | Curcumin | Fruits | [ |
| Hydroxybenzoic acids | Gallic acid | Onion | [ | |
| Flavonoids | Flavonols | Kaempferol | Onions | [ |
| Flavanones | Naringenin | Oranges | [ | |
| Flavanols | Gallocatechin | Tea | [ | |
| Isoflavones | Genistein | Soybeans | [ | |
| Anthocyanins | Pelargonidin | Blackcurrant | [ | |
| Flavones | Apigenin | Parsley | [ | |
| Stilbenes | Resveratrol | Red wine | [ | |
| Lignans | Pinoresinol | Flaxseed | [ | |
| Lariciresinol | ||||
Figure 2Roles of polyphenols on gut microbiota and implications in human health.
Figure 3Metabolism of polyphenols by human gut microbiota.
In vitro modulation of gut microbiota through polyphenol consumption.
| Polyphenol | Strains (spp) | Conditions | Method | Time | Materials | Main Metabolites | Outcome | Ref. |
|---|---|---|---|---|---|---|---|---|
| Raspberry | N.S. 1 | In vitro gastrointestinal digestion with heat-stable α-amylase at 25 °C, 30 min protease, at 95 °C, 35 min and with α-amyloglucosidase, 60 °C, 35 min) | In vitro fermentation | 48 h fermentation | Fecal samples (healthy volunteers) | Propionic acid, butyric acid, acetic acid, isobutyric acid, isovaleric acid, valeric acid, isocaproic acid, caproic acid, and heptanoic acid | Polyphenols had a better prebiotic-like effect, in comparison with the fiber fractions | [ |
| Olive pomace | In vitro simulations of gastrointestinal digestion | In vitro simulated gastrointestinal digestion | Samples were collected after 0, 12, 24, and 48 h of incubation | Feces (healthy volunteers) | Acetate, propionate, and butyrate | ↑ SCFAs, potential antioxidant, and antimicrobial activity. | [ | |
| Red and white grapes | In vitro GI digestion (Infogest protocol) | In vitro GI digestion | 48 h fermentation | Feces (healthy volunteers) | N.S. | ↑ | [ | |
| Predigested mango peel | In vitro model of the colon (TIM-2) using human fecal microbiota and sampled after 0, 24, 48, and 72 h | Dynamic in vitro model of the human colon | 72 h experimental period | Fecal samples (healthy donors) | Acetic acid, propionic acid, butyric acid, valeric acid, formic acid, iso-valeric acid, ammonia | Mango peel fermentation → 80 bacterial genera identified | [ | |
| Green tea, oolong tea, and black tea | To obtain the fecal slurries it was necessary to mix fresh fecal + autoclaved phosphate buffered saline to yield 10% suspensions | In vitro fermentation | 72 h | Fecal samples (healthy volunteers) | Formic acid, acetic acid, propionic acid, butyric acid | ↑ | [ | |
| Grape pomace (GP) | Simulation of the effect of digestive tract was performed by dissolving 900 mg of the lyophilized GP extract into 20 mL of ultra-pure water | In vitro stimulated gastrointestinal digestion | 48 h fermentation | Syrah grape pomace | Acetic acid, butyric acid, formic acid, propionic acid | Until GI digestion, grape pomace extract proved to have antimicrobial activity against pathogenic bacteria | [ | |
| Pomegranate juice, pomegranate pulp, pomegranate peel extract | N.S. | In vitro digestion procedure applied | In vitro GI digestion | 0, 2, 8, 24, 48, 72 h | Fresh fecal samples (three healthy adults) | Urolithin A, urolithin B, gallic acid, catechol, protocatechuic acid, coumaric acid | Pomegranate peel extract→ the best source of microbial substrates at the colonic level | [ |
| Pineapple | In vitro digestion | In vitro gastrointestinal digestion | Samples were incubated and collected at 0, 6, 12, 24, and 48 h | Fecal samples (3 healthy adults) | Propionic acid, acetic acid, p-hydroxybenzoic acid, 3-hydroxybenzoic acid, 4-hydroxyphenyl acetic acid, p-hydroxybenzoic acid | The consumption of pineapple snack bars → the regulation of the antioxidant and anti-inflammatory effects | [ | |
| Red fruit extracts | Potential mechanisms involved in the inhibition of pathogenic bacterial growth analyzed with a well diffusion assay | In vitro fermentation | Growth conditions between 24–48 h | Collected from culture collection, human intestinal tract, isolated from food, probiotic strains combination | N.S. | ↓ | [ | |
| Pomegranate extract (POMx), pomegranate juice (POM juice) | Aliquots of 10 μL of the homogenized stool specimens were inoculated into seven different test broths | In vitro culture tubes | Between 24 h and 7 days | Stool specimens from 8 healthy volunteers | Urolithins A and B, punicalagin A and B, punicalin, glycosyl ellagic acid | ↑ | [ |
1 N.S.—not specified, 2 →—next step, 3 ↑—increase, 4 ↓—decrease.
In vivo modulation of gut microbiota through polyphenol consumption.
| Polyphenol Source | Strains (spp) | Conditions | Method | Time (Fermenation/Incubation/Exposure) | Materials | Main Metabolites | Outcome | Ref. |
|---|---|---|---|---|---|---|---|---|
| Blueberry | Four groups: group A, a normal-fat diet, group B, a high-fat diet, group C, a high-fat diet supplement with polyphenol extract, and group D a high-fat diet supplemented with Orlistat, as a positive control | Administrated as a supplement (200 mg/kg body weight/day) | 12 weeks | C57BL/6 J mice of 4 weeks | N.S. 1 | Supplementation with polyphenol extract ↓ 2 the body weight of the high fat diet-fed mice by 6–7% | [ | |
| Lyophilized jabuticaba seed extract (LJE) |
| Animals were treated to develop cancer (by administrating dimethylhydrazine dihydrochloride (DMH)) | In vivo, experimental design | 2 weeks | Wistar rats | Castalagin | ↑ Bacteroidetes, ↓ Firmicutes (when DMH treated mice received the yogurt or the yogurt with LJE) | [ |
| Grape extract |
| Divided in five groups and the samples were administered intragastrically three times/week | Intragastrically administration | 4 weeks | 5 female BALB/c mice (5 weeks old) | N.S. 1 | The microbiota was not affected by the sample composition or time of treatment | [ |
| Tart cherries | Participants consumed 237 mL of juice daily for 5 days | In vivo human dietary intervention | 5 days | 10 healthy participants (5 = male, 5 = female) | 4-hydroxyphenylpropionic acids, 4-hydroxyphenylacetic acid, quercetin-3-O-glucoride, quercetin-3-O-rutinoside, kaempferol-3-O-rutinoside, | Gut microbiota strongly influences polyphenol metabolites | [ | |
| Herbal tea: ginseng (GS), red ginseng (RGS), notoginseng (NGS), | Eight-week old male mice, 5 experimental groups, daily single dose of herbal saponins at 500 mg/kg or Milli-Q H2O by gavage for 15 consecutive days | In vivo-daily intake of herbal saponins | 15 days | 50 C5777BL/6 8 weeks old male mice | Butyrate | Ingested herbal saponins can increase the beneficial bacteria in the gut of the host | [ | |
| Red raspberry (polyphenolic extracts from whole fruit, seed, and pulp) | Five groups: a low-fat diet, high-fat diet, high-fat diet supplemented with 0.4% by weight-red raspberry (RR) whole fruit polyphenols, 0.1% by weight RR seed polyphenols, 0.3% by weight RR seed polyphenols | Administration of different types of diets | 16 weeks | C57BL/6 male mice | Butyrate, pentahydroxy-urolithin, tetrahydroxy-urolithin | High-fat diets with RR polyphenols have a prebiotic effect on the gut microbiota | [ | |
| Red wine polyphenols | Fecal, and 24 h urine samples (at baseline and after each intervention period) | Consumption of red wine, dealcoholized red wine, and gin | Three consecutive periods of 20 days each with an initial washout period | 9 adult men | Syringic acid, p-coumaric acid, 4-hydroxybenzoic acid, homovanillic acid, hydroxycinnamates, 3,4-dihydroxyphenylacetic acid | Bacterial changes after red wine consumption (±alcohol) have been associated with the excretion of phenolic metabolites | [ | |
| Red wine polyphenols | Four periods: the participants were given a two-week washout period during which they did not consume any red wine, followed by two 30-day intervention periods during which they drank just red wine (272 mL/day) or dealcoholized red wine (272 mL/day), separated by a 5-day washout phase | In vivo study | Two weeks washout period, 2 periods of 30 days each, and between a period of 15 days | Twenty adults (10 met the criteria for metabolic syndrome (MetS), and 10 healthy) | N.S. | ↑ | [ | |
| To obtain a human intestinal microbial suspension, the supernatants prepared from each volunteer’s fecal sample were combined | In vivo, administration by gavage | Four weeks | Germ-free 6-week-old C57BL/6J male mice; 6 healthy volunteers | - | The diversity of the total bacterial community ↑ during CPF treatment | [ | ||
| Carrot | Three groups: control group (CON), carrot dietary fiber (CDF), dephenolized carrot dietary fiber (CDF-DF) | In vivo, oral administration | Seven days | Male BALB/c mice; 3 healthy donors | Acetic acid, butyric acid, propionic acid, valeric acid | CDF-fed mice: ↑ | [ |
1 N.S.—not specified, 2 ↓—decrease, 3 ↑—increase.